Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Harbinger Health
AddedFeb 15, 2024
UpdatedJun 18, 2026
Harbinger Health

Harbinger Health

Series B

Harbinger Health: Pioneering early blood cancer detection through innovative testing.

HQ
Cambridge, MA, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

Harbinger Health, founded with the mission to revolutionize cancer care, focuses on pioneering early cancer detection through innovative blood testing. The company's vision is to create a future where cancer can be detected at its earliest stages, making treatment more accessible and effective for everyone. Harbinger Health aims to address the limitations of current cancer detection tools, which often identify the disease only after it has progressed.

Notable affiliated individuals and investors include leading experts in oncology and biotechnology, though specific names are not provided. Harbinger Health has achieved significant milestones in developing cutting-edge blood tests that promise to transform early cancer detection. Its impact lies in potentially saving countless lives by enabling earlier and more accurate diagnosis, thereby improving treatment outcomes and accessibility for patients worldwide.

Harbinger Health - Similar Companies

Helio Health logo

Helio Health

heliohealth.com

Hawkeye Bio logo

Hawkeye Bio

hawkeyebio.com

Thrive Earlier Detection logo

Thrive Earlier Detection

Babson Diagnostics logo

Babson Diagnostics

babsondx.com

Pharus Diagnostics logo

Pharus Diagnostics

pharusdx.com

Harae Dx logo

Harae Dx

haraedx.com

BloodQ logo

BloodQ

bloodq.com

Metfora logo

Metfora

metfora.com

Early Detection logo

Early Detection

cancer.us

Lucence logo

Lucence

lucence.com

GRAIL logo

GRAIL

grail.com

Naveris logo

Naveris

naveris.com

Signatur Biosciences logo

Signatur Biosciences

signatur.bio

Cirina logo

Cirina

Aigene logo

Aigene

a-i-gene.com

Harbinger Health - Quick Facts

Who are Harbinger Health's competitors?

Companies similar to Harbinger Health include Helio Health, Hawkeye Bio, Thrive Earlier Detection and Babson Diagnostics.

When was Harbinger Health founded?

Harbinger Health was founded in 2018.

Where is Harbinger Health's headquarters located?

Harbinger Health's headquarters is located in Cambridge, MA, US.

When was Harbinger Health's last funding round?

Harbinger Health's most recent funding round was for $140M (USD) in September 2023.

How much has Harbinger Health raised to-date?

As of Sep 28, 2023, Harbinger Health has raised a total of $190M (USD).

How many employees does Harbinger Health have?

Harbinger Health has 77 employees as of Feb 4, 2024.

Harbinger Health - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
  • HealthTech
Geographic Exposure
  • Global
Revenue
  • Recurring
Main Product
  • Blood Tests
Tags
  • SaaS
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified